Taizhou Mabtech Pharmaceutical Co.,Ltd
Quick facts
Marketed products
- Xolair · Respiratory
Phase 3 pipeline
- CMAB007 · Oncology
CMAB007 is a monoclonal antibody that targets and inhibits a specific immune checkpoint or tumor-associated antigen to enhance anti-tumor immunity. - CMAB009 · Oncology
CMAB009 is a monoclonal antibody targeting a specific immune checkpoint or tumor-associated antigen to modulate immune response against cancer cells. - CMAB015 · Oncology
CMAB015 is a monoclonal antibody that targets and inhibits a specific immune checkpoint or tumor-associated antigen to enhance anti-tumor immunity.
Phase 1 pipeline
- Approved technology Enlituo
- CMAB017
- CMAB809
- New technology Enlituo
- Post-change CMAB807
- Process-Changed CMAB007
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: